Seeking Molecular Signatures for Nasopharyngeal Carcinoma

寻找鼻咽癌的分子特征

• 批准号: 354751
• 负责人: Liu Fei-Fei
• 金额: $ 83.6万
• 依托单位: University Health Network (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-10-01 至 2021-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=354751&lang=en
• 关键词: Biomarkers; Circulating Biomarkers; Distant Metastasis; Genomics; Head And Neck Cancer; Microrna; Molecular Signature; Nasopharyngeal Carcinoma; Prognostic Signatures; Translational Medicine

Nasopharyngeal carcinoma (NPC) is a unique cancer of the head & neck region, wherein most diagnosed patients are relatively young (peak incidence between 40-45 years) and have advanced disease; the 5-year overall survival rate of such patients is a dismal

鼻咽癌（Nasopharyngeal carcinoma，NPC）是头颈部的一种独特癌症，其中大多数确诊患者相对年轻（发病高峰在40-45岁之间）并且具有晚期疾病;此类患者的5年总生存率令人沮丧。